774 kr
Läs direkt efter köp
774 kr
Läs direkt efter köp
774 kr
Läs direkt efter köp
1 257 kr
Skickas inom 5-8 vardagar
886 kr
Läs direkt efter köp
A brand-new edition of the bestselling guide to hematologic malignancies.
An international team of contributors come together to present all clinically relevant aspects of leukemias, lymphomas, and myelomas. Using clear terminology, the book discusses salient features, diagnostic procedures, prognosis, and treatments for these cancers.
Following on the successful steps of the first edition, this Second Edition covers:
various types of leukemias, lymphomas, and myelomas utilizing stem cell transplantation side-effects of various treatments future prospects for leukemia, lymphoma, and myeloma targeted therapies and history of the cancers information and support sources for patients.1 054 kr
Skickas inom 10-15 vardagar
892 kr
Läs direkt efter köp
A brand-new edition of the bestselling guide to hematologic malignancies.
An international team of contributors come together to present all clinically relevant aspects of leukemias, lymphomas, and myelomas. Using clear terminology, the book discusses salient features, diagnostic procedures, prognosis, and treatments for these cancers.
Following on the successful steps of the first edition, this Second Edition covers:
various types of leukemias, lymphomas, and myelomas utilizing stem cell transplantation side-effects of various treatments future prospects for leukemia, lymphoma, and myeloma targeted therapies and history of the cancers information and support sources for patients.1 204 kr
Läs direkt efter köp
Highly Commended, BMA Medical Book Awards 2014
Chronic myeloid leukemia is a clonal disease that results from an acquired genetic change in a single pluripotential hemopoietic stem cell. Efforts to confront this disease have been assisted by advances in cellular and molecular biology and the speed at which these findings have transformed the therapeutic algorithm. Nevertheless, there is some uncertainty with regards to how best to assess efficacy of treatment, especially with regards to the most appropriate surrogate markers for overall survival. From the standpoint of biology and clinical management, this handbook provides an authoritative state-of-the-art review of current and developing progress.
3 980 kr
Skickas inom 7-10 vardagar
1 043 kr
Skickas inom 10-15 vardagar
1 231 kr
Läs direkt efter köp
Highly Commended, BMA Medical Book Awards 2014
Chronic myeloid leukemia is a clonal disease that results from an acquired genetic change in a single pluripotential hemopoietic stem cell. Efforts to confront this disease have been assisted by advances in cellular and molecular biology and the speed at which these findings have transformed the therapeutic algorithm. Nevertheless, there is some uncertainty with regards to how best to assess efficacy of treatment, especially with regards to the most appropriate surrogate markers for overall survival. From the standpoint of biology and clinical management, this handbook provides an authoritative state-of-the-art review of current and developing progress.
1 219 kr
Tillfälligt slut